August 30, 2021 · STOCK Act disclosure
Representative Kurt Schrader (Democrat-OR) bought Ultragenyx Pharmaceutical Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on August 30, 2021 and was disclosed on September 8, 2021 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.